CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...